Dotmatics announces licensing agreement for informatics software with Compugen

  • Compugen selects Dotmatics’ cloud-based LIMS and ELN solution to drive efficient drug discovery
  • Agreement marks the first implementation of Dotmatics SaaS technology in Israel, further extending global access

Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has entered a licensing agreement with Compugen, a clinical-stage drug discovery and development company focused on immuno-oncology. The multi-year agreement will provide Compugen scientists based at the Company’s R&D facility in Israel with a single information management platform.

The agreement will give Compugen access to Dotmatics’ industry leading SaaS technology, including Bioregister, Inventory, Studies Notebook and Platform applications. The tools enable gathering, analyzing and visualizing project data and will facilitate project teams to become more efficient and make better informed decisions faster. The technology will replace Compugen’s current Laboratory Information Management System (LIMS) and Electronic Lab Notebook (ELN), and may contribute to Compugen’s unique, predictive, cloud-based computational approach to identifying novel immuno-oncology drug targets and biomarkers. Dotmatics’ single platform will serve across different disciplines, consolidating research data to improve efficiency and productivity.

We are delighted to have been selected by Compugen to provide a software solution that meets the company’s needs and aims to improve productivity. It is an exciting advancement to have our first implementation in the antibody research industry in Israel, and we look forward to further global growth.

Erran Twigg, VP EMEA, Dotmatics

We chose to work with Dotmatics due to its position as a leading, single platform for high quality scientific software. We believe that Dotmatics’ technology of integrated, configurable software is well suited to meet our specific and unique data management requirements, and will enable improved usage, accessibility and sharing of our proprietary generated information with the various teams within Compugen.

Eran Ophir, Ph.D. Vice President, Research and Drug Discovery, Compugen

For further information on Dotmatics, please visit


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dotmatics. (2021, March 03). Dotmatics announces licensing agreement for informatics software with Compugen. News-Medical. Retrieved on July 13, 2024 from

  • MLA

    Dotmatics. "Dotmatics announces licensing agreement for informatics software with Compugen". News-Medical. 13 July 2024. <>.

  • Chicago

    Dotmatics. "Dotmatics announces licensing agreement for informatics software with Compugen". News-Medical. (accessed July 13, 2024).

  • Harvard

    Dotmatics. 2021. Dotmatics announces licensing agreement for informatics software with Compugen. News-Medical, viewed 13 July 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Dotmatics releases Platform 22.1